AI Startup Latest Funding Deal: Cohere raised $500M Series D round

Artificial Intelligence Outpace Bio | Revolutionizing Cell Therapy

Enterprise, Healthcare Facilities, Cell Therapy, Protein Design, Cell Engineering, Immuno-oncology Seattle, WA, United States

Artificial Intelligence

Outpace Bio | Revolutionizing Cell Therapy

Healthcare Facilities, Cell Therapy, Protein Design, Cell Engineering, Immuno-oncology

Seattle, WA, United States

"Cohere empowers every developer and enterprise to build amazing products and capture true business value with language AI"

Aidan Gomez, Co-founder, CEO

Get Started

We use AI-powered protein design to create proteins that program engineered immune cells for improved function inside patients. We are building a robust pipeline of engineered T cell therapies with curative potential that leverage Outpace technologies across modalities, targets, and indications. Our lead program OPB-101 is a mesothelin (MSLN) autologous CAR-T program with curative potential powered by Outpace efficacy & safety technologies. Today, only a tiny fraction of cancers can be cured. This is because cancer is a complex biological system, and our bodies have learned to make the wrong decisions as they fight. Our immune system evolved to beat back infections, not our own cells. Even the most advanced cancer treatments fail to address this. Rather than one gene or one protein solutions that reuse existing biomolecules, we need to create better biology that can address the multiple mechanisms that stand in the way of curing tumors.

Total Funding: $200M

Funding Stage: Series B

Business Stage: Scaling Up

Market: B2B

Company Size: 51 to 100

Founded: 2020

Aug 2024

Outpace Bio raised $144M Series B round. Total funding reached to $200M

AI Startups Funding Deals IntelligenceTry for Free

Date

Round

$ Raised

Investors

08/01/2024

Series B

$144M

RA Capital Management, Qatar Investment Authority, Surveyor Capital, Sheatree Capital, Black Opal Ventures, Alexandria Venture Investments, ARTIS Ventures, Playground Global, Bristol Myers Squibb, Abstract Ventures, Civilization Ventures, Mubadala Capital, Breton Capital Ventures, WRF Capital, Sahsen Ventures

Date : 08/01/2024

Round: Series B

$ Raised: $144M

Investors: RA Capital Management, Qatar Investment Authority, Surveyor Capital, Sheatree Capital, Black Opal Ventures, Alexandria Venture Investments, ARTIS Ventures, Playground Global, Bristol Myers Squibb, Abstract Ventures, Civilization Ventures, Mubadala Capital, Breton Capital Ventures, WRF Capital, Sahsen Ventures

For AI Startup Founders

Get introduced to VC/PE/CVC investors

Get Started

For Investors at VC/PE firms

Get introduced to AI Startup founders or founders at Outpace Bio

Marc Lajoie
Founder & CEO

Scott Boyken
Co-founder & Chief Technology Officer

Outpace Bio - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups Outpace Bio - Manage Profile

World's Most Promising AI Startups

World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals

Get Started